SPIRO HYDANTOIN ALDOSE REDUCTASE INHIBITORS DERIVED FROM 8-AZA-4-CHROMANONES

被引:36
作者
SARGES, R
GOLDSTEIN, SW
WELCH, WM
SWINDELL, AC
SIEGEL, TW
BEYER, TA
机构
[1] Pfizer Central Research, Groton
关键词
D O I
10.1021/jm00169a005
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of spiro hydantoins derived from 8-azachromanones (2,3-dihydro-4H-pyrano[2,3-6]pyridin-4-ones) has been prepared and tested for aldose reductase inhibitory activity. The standard Bucherer-Bergs conditions had to be drastically modified to increase yields from less than 1% to an acceptable 50% range. One of the most potent compounds was m-6'-chloro-2',3'-dihydro-2'-methylspiro[imidazolidine-4,4'-4'H-pyrano[2,3-b]pyridine;-2,5-dione; resolution of this compound showed that the 2'R,4’S enantiomer 16 was the most active spiro hydantoin in this series with an IC50 of 7.5 X 10-9 against human placenta aldose reductase. © 1990, American Chemical Society. All rights reserved.
引用
收藏
页码:1859 / 1865
页数:7
相关论文
共 11 条
[1]  
CUE BW, 1984, Patent No. 4431828
[2]  
GODDARD CJ, 1987, Patent No. 4716231
[3]  
HAYMAN S, 1965, J BIOL CHEM, V240, P877
[4]  
KUHLA DE, 1975, Patent No. 3879403
[5]  
Major R. T., 1941, J AM CHEM SOC, V63, P1368
[6]  
MURTIASHAW CW, UNPUB
[7]   CP-45,634 - NOVEL ALDOSE REDUCTASE INHIBITOR THAT INHIBITS POLYOL PATHWAY ACTIVITY IN DIABETIC AND GALACTOSEMIC RATS [J].
PETERSON, MJ ;
SARGES, R ;
ALDINGER, CE ;
MACDONALD, DP .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1979, 28 (04) :456-461
[8]  
RONFELD RA, UNPUB
[9]   SPIRO HYDANTOIN ALDOSE REDUCTASE INHIBITORS [J].
SARGES, R ;
SCHNUR, RC ;
BELLETIRE, JL ;
PETERSON, MJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (01) :230-243
[10]   SYNTHESIS, ABSOLUTE-CONFIGURATION, AND CONFORMATION OF THE ALDOSE REDUCTASE INHIBITOR SORBINIL [J].
SARGES, R ;
BORDNER, J ;
DOMINY, BW ;
PETERSON, MJ ;
WHIPPLE, EB .
JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (11) :1716-1720